Data Bridge Market Research analyses that the nucleic acid Testing-NAT instrumentation market will exhibit a CAGR of around 6.05% for the forecast period of 2021-2028. Rise in the trend of personalized medicine, advancements in tools for synthetic genome designs and rising prevalence of infectious diseases are the major factors attributable to the growth of nucleic acid Testing-NAT instrumentation market. Therefore, the market value, currently standing on USD 1,378.06 million will rocket up to USD 2,204.73 million by the year 2028.
Nucleic acid test is a medical technology that is used to detect the presence of any virus of bacteria which act as disease-causing pathogens. The nucleic acid test is conducted with the help of NAT instrumentation using biological samples such as urine, blood, tissues and so on.
Rising demand for nucleic acid test kits from blood transfusion centres and blood banks is one of the major factors fostering the growth of nucleic acid Testing-NAT instrumentation market. Rising expenditure for technological advancements and research and development by the healthcare industries is another important factor bolstering the growth of nucleic acid Testing-NAT instrumentation market. Rising prevalence of genetic diseases and other infectious diseases such as malaria, dengue and so on will further create lucrative market growth opportunities.
The countries covered in the nucleic acid Testing-NAT instrumentation market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Access Report Summary @ https://www.databridgemarketresearch.com/reports/global-nucleic-acid-testing-nat-instrumentation-market
North America dominates the nucleic acid Testing-NAT instrumentation market and will continue to flourish its trend of dominance during the forecast period. This is because of the increasing expenditure for research and developmental proficiencies by the major key players. Rising prevalence of infectious diseases is another factor fostering the market growth in this region. Asia-Pacific on the other hand is projected to score the highest CAGR for the forecast period owing to the increased public and private expenditure for the development of healthcare infrastructure and increased awareness regarding nucleic acid testing.
The major players covered in the nucleic acid Testing-NAT instrumentation market report are Novartis AG, BD, Abbott, Danaher., Thermo Fisher Scientific Inc., bioMérieux SA, Biomerica, Inc., F. Hoffmann-La Roche Ltd, Siemens AG, Johnson & Johnson Services, Inc., Beckman Coulter, Inc., Hologic, Inc., Bio-Rad Laboratories, Inc., Bayer AG, Illumina, Inc., Grifols, S.A., Quest Diagnostics Incorporated. and Tecan Trading AG,among other domestic and global players.
About Data Bridge Market Research, Private Ltd
Data Bridge Market Research Pvt Ltd is a multinational management consulting firm with offices in India and Canada. As an innovative and neoteric market analysis and advisory company with unmatched durability level and advanced approaches. We are committed to uncover the best consumer prospects and to foster useful knowledge for your company to succeed in the market.
Data Bridge Market Research is a result of sheer wisdom and practice that was conceived and built-in Pune in the year 2015. The company came into existence from the healthcare department with far fewer employees intending to cover the whole market while providing the best class analysis. Later, the company widened its departments, as well as expands their reach by opening a new office in Gurugram location in the year 2018, where a team of highly qualified personnel joins hands for the growth of the company. “Even in the tough times of COVID-19 where the Virus slowed down everything around the world, the dedicated Team of Data Bridge Market Research worked round the clock to provide quality and support to our client base, which also tells about the excellence in our sleeve.”
Contact:
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
A new research report by Future Market Insights on the global nucleic acid testing market reveals has been titled, ‘Nucleic Acid Testing Market – Global Industry Analysis 2012 – 2016 and Opportunity Assessment 2017 – 2027,’ and assesses the growth prospects of the nucleic acid testing market for the next nine years.
The report also comprises preferences of patients and doctors across the globe, which helps in accessing the current as well as future demand of the nucleic acid testing market.
It may lead to an increase in healthcare costs, with the promise that quality of care will go up.Download Sample Copy@ https://www.futuremarketinsights.com/reports/sample/rep-gb-1106The healthcare system is in a phase where access to capital is constantly diminishing.
Healthcare institutions are either postponing large capital-intensive projects or allocating resources to specialty areas that offer a high ROI.
Providers and insurers are strategizing to tap into the available opportunities in this demographic.
Baby boomers around the globe are actively taking charge of their health.
